– Scewo is the winner –

Scewo AG has reason to celebrate.

They are the winner of the Swiss Medtech Award 2021 worth 50,000 Swiss francs. Scewo AG is the inventor and manufacturer of a stair-climbing power wheelchair that is redefining freedom for people with limited mobility, and also has the potential to conquer world markets. 

GO TO media release

go to Press photos

Who can apply?

Participation in the Swiss Medtech Award is open to companies, research institutions or syndicates from the Swiss medical technology industry.

The following criteria must be met in order to be admitted to the competition. In cases where it is unclear whether a candidate fulfils the criteria, the jury has final say. 

Project-related criteria

At least one of the following project-related criteria must be met. 

  • Patient benefit generated
    The candidates develop new medical products and can demonstrate a benefit to patients – in studies or on the market.
  • New health care solutions
    The candidates have implemented new solutions that lead to identifiable cost savings in the healthcare sector.
  • Pioneering advancements
    The candidates have contributed to the development of groundbreaking technologies or procedures that will strengthen the Swiss medical industry.

Formal criteria

Both of the formal criteria below must be met. 

  • «Swissness» factor
    The achievements and provision of services must have been performed to a significant extent within Switzerland. 
  • Record of achievement
    Candidates can provide supporting documents and/or references as evidence of their achievements.

In addition, applicants must read and accept our Terms of Participation.

Bettina Knellwolf

Project Manager

Events

+41 31 330 97 77

E-Mail

Important dates

Jury

Prof Dr Mirko Meboldt

President of the Jury

Chair of Product Development

& Engineering

ETH Zurich

Prof Dr med Edouard Battegay

Member of the Jury

Head Innovation Hub, ICMC,

University Zurich

Owner IntelliXess AG

Hans Ulrich Lehmann

Member of the Jury

Senior Vice President Technology

Ypsomed

Sabina Sperisen

Member of the Jury

CEO

Lichtsteiner Foundation

Stephan Oehler

Member of the Jury

Head of Technology & Testing

Straumann

Donors

 

The Lichtsteiner Foundation helps pioneers bring their inventions to life by investing in early stage start-ups in the fields of medical technology, life science, mental health, public health and wellbeing. The foundation focuses on impact investing by providing funding in the form of equity.

 

The Straumann Group is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Dental Wings, Medentika, Neodent, NUVO, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, biomaterials and digital solutions for use in tooth replacement and restoration or to prevent tooth loss.

 

With over 30 years’ experience, the Ypsomed Group is a renowned diabetes specialist and principle developer and manufacturer of injection and infusion systems for self-medication. As a leader in innovation and technology, Ypsomed is the preferred partner of pharmaceutical and biotech companies for the supply of injections pens, autoinjectors and infusion systems which administer liquid drugs. Ypsomed promotes its product portfolio under the following umbrella brands: mylife Diabetescare sells directly to patients or via pharmacies and clinics, and YDS Ypsomed Delivery Systems deals business-to-business with pharmaceutical companies.